Skip to main content
Fig. 4 | BMC Psychiatry

Fig. 4

From: Weight gain and comorbidities associated with oral second-generation antipsychotics: analysis of real-world data for patients with schizophrenia or bipolar I disorder

Fig. 4

Incidence of Key/Other Cardiometabolic Conditions by BMI in the 12 Months Post-Index in Patients With No Cardiometabolic Conditions at Baseline. (A) Patients With SZ, and (B) Patients With BD-I. BD-I, bipolar I disorder; BMI, body mass index; CM, cardiometabolic; CSWG, clinically significant weight gain; SZ, schizophrenia

Back to article page

BMC Psychiatry

ISSN: 1471-244X

Contact us